Bob Casey

We urge Congress to provide resources to support efforts to scale up inpatient care capacity.

We urge Congress to provide resources to support efforts to scale up inpatient care capacity.

The report paints a picture of a system in crisis.

Underfunded and understaffed State agencies have fallen behind on the basic duties that they are charged with executing on.

Just imagine the horror of an 84-year-old woman whose leg was broken at a nursing home in Pennsylvania.

If we as Americans claim that ours is the greatest country in the world, we must insist upon, and invest in, and ensure that we have the best long term care system in the world.

I directed my staff and the Committee to investigate the capacity of State inspection agencies to enforce health and safety standards.

We urge Congress to provide resources to support efforts to scale up inpatient care capacity.

But my question is, why stop at insulin?

We are happy the Inflation Reduction Act got those costs down for Medicare Part D beneficiaries.

We are happy the Inflation Reduction Act got those costs down for Medicare Part D beneficiaries.

I don't think I have to explain to anyone in this room. I think there is a consensus, when we go back home, we hear from people about the cost of prescription drugs.

But my question is, why stop at insulin?

But my question is, why stop at insulin?

We are happy the Inflation Reduction Act got those costs down for Medicare Part D beneficiaries.

I think there is a consensus, when we go back home, we hear from people about the cost of prescription drugs.

It will be a huge issue among many difficult issues in this reauthorization.

We learned a horrible lesson in the pandemic, which--and the way I look at it, kind of a national failure when we couldn't provide the kind of PPE that we needed.

We need it and we need notification both with drugs and devices.

It will be a huge issue among many difficult issues in this reauthorization.

We learned a horrible lesson in the pandemic, which--and the way I look at it, kind of a national failure when we couldn't provide the kind of PPE that we needed.

We need it and we need notification both with drugs and devices, not only when manufacturing is disrupted, but also when there is a huge surge in demand.

It will be a huge issue among many difficult issues in this reauthorization.

We learned a horrible lesson in the pandemic, which--and the way I look at it, kind of a national failure when we couldn't provide the kind of PPE that we needed.

Senator, kids can't do their homework, which kind of crystallized it for me.